Bioscience

Lacosamide validated as promising therapy for uncontrolled partial-onset seizures

February 25, 2010

By Flinn Foundation

[Source: EurekaAlert] – A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients. Researchers from the Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Thomas Jefferson University Medical School, Arkansas Epilepsy Program, Schwarz Biosciences and Johns Hopkins University Hospital conducted this study which is available early online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

For more information: Lacosamide validated as promising therapy for uncontrolled partial-onset seizures